Xtalks Editorial

The project includes advanced manufacturing and packaging technologies, plus a new distribution facility expected to be fully operational in 2028. Photo courtesy of Johnson & Johnson.

The Johnson & Johnson Florida investment will expand ACUVUE contact lens manufacturing, packaging and distribution capacity in Jacksonville.

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

Cypsedo (cipepofol) injection is to be used for the induction of general anesthesia in adults undergoing surgery.

News June 23, 2026

Deck Bio on Solid Tumor Immunotherapy, Talent and Biotech Infrastructure

Blogs June 22, 2026

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

News June 19, 2026

News Life Science News Pharma News Biotech News Medical Device News Healthcare News Videos Blogs Life Sciences Quizzes & Polls

Vitals Highlights

Deck Bio on Solid Tumor Immunotherapy, Talent and Biotech Infrastructure

Blogs June 22, 2026

Cell Therapy for Degenerative Disc Disease: Clinical Trial Priorities and Regulatory Rigor

Blogs June 18, 2026

Bone Screws Don’t Have to Stay Forever: Bioretec on Absorbable Metal Fixation

Blogs June 18, 2026

Chiesi on Sustainability in Asthma and COPD R&D

Blogs June 18, 2026

Organon on Why Women’s Life Stages Matter in Dermatology Clinical Research

Blogs June 18, 2026

Clinical Development Lessons from a Phase II Ovarian Cancer Study

Blogs June 18, 2026

Obesity and MASH Drug Development: What Comes After Weight Loss?

Blogs June 18, 2026

National HIV Testing Day 2026: From Lab-Based Tests to Self-Testing

Blogs June 17, 2026

Calidi Biotherapeutics on Advancing Systemic Virotherapy for Metastatic Cancer

Blogs June 16, 2026

Noveome Biotherapeutics on Rethinking Trial Sites in Rare Neonatal Disease

Blogs June 15, 2026

Pharma and Biotech IPOs of 2026: A Running List

Blogs June 12, 2026

Why Attend the DIA Canada Annual Meeting 2026

Blogs June 10, 2026

MedTech M&A in 2026: Tracking Deal Activity

MedTech M&A 2026, medtech m&a news 2026, medical device m&a news 2026

Medical Device Blogs June 9, 2026

Hepcludex (Bulevirtide) Becomes First FDA-Approved Treatment for Hepatitis D

News June 9, 2026

Healthcare IPOs in 2026: A Roundup

News June 9, 2026

Healthcare M&A in 2026: A Roundup of Deals

Healthcare M&A 2026, healthcare m&a news 2026

Healthcare Blogs June 8, 2026

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

June 24, 2026

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

News June 23, 2026

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

News June 19, 2026

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

News June 19, 2026

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi

The five-day pill course is intended for people who have been exposed to COVID-19 but have not yet developed symptoms.

News June 19, 2026

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs

News June 17, 2026

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

Hemab is studying subcutaneous, or under-the-skin, treatments for rare bleeding disorders.

News June 15, 2026

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

June 24, 2026

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

News June 23, 2026

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

News June 19, 2026

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

News June 19, 2026

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi

News June 19, 2026

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs

News June 17, 2026

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

News June 15, 2026

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

News | Approvals News | Healthcare News | Life Science News | Pharma News

June 23, 2026

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

News June 19, 2026

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi

News June 19, 2026

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs

News June 17, 2026

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

News June 15, 2026

Seaport Therapeutics IPO Raises $260M for Neuropsychiatry Pipeline

News June 15, 2026

Odyssey Therapeutics IPO Aims to Address IBD “Therapeutic Ceiling”

News June 12, 2026

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

News | Approvals News | Biotech News | Life Science News | Pharma News

June 19, 2026

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi

News June 19, 2026

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs

News June 17, 2026

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

News June 15, 2026

Seaport Therapeutics IPO Raises $260M for Neuropsychiatry Pipeline

News June 15, 2026

Ebglyss (Lebrikizumab) Approval Adds 8-Week Maintenance Option for Eczema

News June 12, 2026

Odyssey Therapeutics IPO Aims to Address IBD “Therapeutic Ceiling”

News June 12, 2026

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

June 24, 2026

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

News June 19, 2026

Mobia Medical IPO Raises $150M for Stroke Recovery Device

News June 12, 2026

MiniMed IPO Points to Smarter Diabetes Devices

News May 5, 2026

FDA Clears Custom Titanium Cranial Implant for Skull Repair

News May 4, 2026

Alamar Biosciences IPO Raises $219.9M for Blood-Based Biomarker Tools

News April 28, 2026

New RAPID Pathway Could Speed Medicare Coverage for Certain Medical Devices

News April 27, 2026

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

News | Approvals News | Healthcare News | Life Science News | Pharma News

June 23, 2026

Healthcare IPOs in 2026: A Roundup

News June 9, 2026

GMR Solutions IPO Brings Ambulance Services to the NYSE

News June 5, 2026

Hantavirus Cruise Ship Outbreak Leaves 3 Dead, WHO Investigates Source

News May 5, 2026

New Report Finds 75% of Women Skip Healthcare Due to Scheduling Constraints

News May 4, 2026

500,000 UK Biobank Records Leaked and Listed for Sale on Alibaba

News April 27, 2026

Only 9% of Americans Know How to Maintain Brain Health, Alzheimer’s Association Finds

News April 22, 2026

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

News June 24, 2026

Precision Oncology in Lung Cancer with Boehringer Ingelheim’s Itziar Canamasas and Volker Teichgräber — Episode 261

Life Science Podcast June 24, 2026

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

News June 23, 2026

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

Vitals Highlights

News

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

Life Science News

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

Pharma News

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs

Biotech News

Utebzi Approved as First Oral Carbapenem Antibiotic for Complicated UTIs

Xocova (Ensitrelvir): First Oral COVID-19 PEP Drug by Japan’s Shionogi

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

Medical Device News

Johnson & Johnson Expands ACUVUE Manufacturing With $1B Florida Investment

Ambelvist FDA Approval Expands Low-Dose MRI Contrast Agent Options

Mobia Medical IPO Raises $150M for Stroke Recovery Device

MiniMed IPO Points to Smarter Diabetes Devices

Healthcare News

FDA Approves Cypsedo (Cipepofol), A New IV Anesthetic for Surgery

Healthcare IPOs in 2026: A Roundup

GMR Solutions IPO Brings Ambulance Services to the NYSE

Hantavirus Cruise Ship Outbreak Leaves 3 Dead, WHO Investigates Source

Based on your interests

Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.

To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Privacy Policy

EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC.

Welcome

Who we are

Our EU and UK Representatives

How to Contact Us

What personal data we collect

Data Accuracy

How We Collect Your Personal Data

Why We Use Your Personal Data

Your Rights

How to exercise your rights

How long we hold your personal data

Who do we share your personal data with?

Do we transfer personal data Overseas?

Third-party links

Marketing

How to withdraw consent

Do we use automated decision-making or profiling?

How We Keep Your Personal Data Secure

How to complain

TERMS OF USE